Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism
Abstract Background Patients with salt-sensitive hypertension are often accompanied with severe renal damage and accelerate to end-stage renal disease, which currently lacks effective treatment. Fibroblast growth factor 21 (FGF21) has been shown to suppress nephropathy in both type 1 and type 2 diab...
Guardado en:
Autores principales: | Hua-Chun Weng, Xin-Yu Lu, Yu-Peng Xu, Yi-Hong Wang, Dan Wang, Yi-Ling Feng, Zhang Chi, Xiao-Qing Yan, Chao-Sheng Lu, Hong-Wei Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/42f916f3a833486b840d8b7c6447bf5d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology
por: Alba Martinez, et al.
Publicado: (2021) -
Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
por: Junli Liu, et al.
Publicado: (2021) -
Editor'den [Editorial] 30. Yilimizi Kutluyoruz [We are celebrating the 30th Anniversary]
por: N. Leyla Acan, et al.
Publicado: (2006) -
The insulin centennial—100 years of milestones in biochemistry
por: Alan D. Attie, et al.
Publicado: (2021) -
In memoriam: the maestro of bile acids: Alan F. Hofmann (1931–2021)
por: Paul A. Dawson, et al.
Publicado: (2021)